1McLemore LB, Horton JL, Antolak JA. Calculation of the 3-D dose distribution surrounding a 103Pd stent. Cardiovasc Radiat Med, 2001, 2:181-190.
2Hehrlein C, Steintz M, Kinscherf R, et al. Pure β-particle-enitting stents inhibit neointima formation in rabbits. Circulation, 1996, 93: 641-645.
3Sioshansi P, Bricault RJ Jr. Low-energy 103Pd gamma (X-ray) source for vascular brachytherapy. Cardiovasc Radiat Med, 1999, 1: 311-312.
4Fajardo LF. The nature of arterial restenosis after angioplasty. Int J Radiat Oncol Biol Phys, 1998, 40: 761-763.
5Fischman DL, Leon MB, Baim D, et al. A randomized comparison of coronary stent placement and balloon angioplasty in the treatment of coronary artery disease. New Engl J Med, 1994, 331: 496-501.
6Carter AJ, Laird JR, Kafe WM, et al. Coronary stenting with a novel stainless steel balloon expendable stent: determinants of neointimal formation and changes in arterial geometry after placement in an atherosclerotic model. J Am Coll Cardiol, 1996, 27: 1270-1277.
7Condado JA, Waksman R, Gurdiel O, et al. Long-term angiographic and clinical outcome after percutaneous transluminal coronary angioplasty and intracoronary radiation therapy in human. Circulation, 1997, 96: 727-732.
8Wilcox JN, Waxman R, King SB, et al. Role of adventitia in the arterial response to angioplasty. In: Waksman R, King SB, Mould RF, eds.Vaseular brachytherapy. Veenendal: Nucletron, 1996. 17-30.
9Scott NA, Ross CE, Dunn B, et al. Identification of a potential role for the adventitia in vascular lesion formation after balloon overstretch injury of porcine coronary arteries. Circulation, 1996, 93: 2178-2187.
10Browne E, Firestone RB. Table of radioisotopes. In: Shirley VS, Ed.New York: Wiley Interscience Publications, 1988. 102-105.
